BRIDGE PHARMA
Dead / Abandoned — Abandoned — failure to respond (as of 10 Sept 2024)
What this means for you
This application is over — abandoned 09 Sept 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97759618
- Mark type
- Stylized text
- Filed
- 18 Jan 2023
- Abandoned
- 09 Sept 2024
- Attorney of record
- Lisel M. Ferguson
Goods and services
- Class 042 — Scientific and technological services: Scientific research and development of therapeutics, disinfectants, diluents, and vaccines for the treatment of dehydrations, low potassium levels, bleeding, infection and pain
Owner
- Bridgewest International Holdings LLC, Miami, FL, US
Prosecution history
- 25 Apr 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Apr 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Apr 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 10 Sept 2024 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 10 Sept 2024 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 07 Aug 2024 — REVIEW OF CORRESPONDENCE COMPLETE
- 07 Aug 2024 — ATTORNEY REVIEW COMPLETED
- 07 Aug 2024 — DIVISIONAL PROCESSING COMPLETE
- 14 May 2024 — DIVISIONAL REQUEST RECEIVED
- 06 Aug 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 07 Jun 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 07 Jun 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 14 May 2024 — TEAS REQUEST TO DIVIDE RECEIVED
- 07 Mar 2024 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 07 Mar 2024 — FINAL REFUSAL E-MAILED